Take a deeper dive


Webinar: The Path to IND – Roadblocks, Milestones, and Regulatory Strategy

On November 14, Nuventra’s Todd Shearer and Brian Furmanski will lead a webinar titled “The Path to IND: Roadblocks, Milestones, and Regulatory Strategy.”

Key takeaways will include:

  • The basics of an IND
  • How to select your FIH dose
  • General study requirements for an IND
  • Pitfalls to avoid
  • Strategies for your pre-IND meeting
  • Tips for interacting with the FDA

Dr. Shearer has 16+ years of expertise in Pharmacokinetics, Toxicokinetics, Drug Metabolism, PK/PD, Nonclinical and Clinical Pharmacology, and Bioanalysis.

Dr. Furmanski has 10+ years of drug development experience and has recently spent 3 years as a reviewer at the FDA, where he reviewed and provided regulatory advice for over 200 INDs spanning across all phases of development.

The webinar is free of charge. Register here.